ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,345Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 22

$885K Total Retail Price of All Prescriptions

Rank: 1 out of 22

452 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

76% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 46%.

Schedule Three
Controlled Substances

13% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

6% of this provider’s 1,156 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$166 was the average price of a prescription from this provider, compared to $129 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OXYCODONE HCL 635 94 S2 1 1
MORPHINE SULFATE ER 502 89 S2 2 6
GABAPENTIN 384 99 3 2
OXYCONTIN 371 79 S2 4 3
BACLOFEN 336 69 5 11
ENDOCET 185 31 S2 6 8
CYCLOBENZAPRINE HCL 182 51 R 7 13
HYDROMORPHONE HCL 182 23 S2 7 12
CARISOPRODOL 147 0 R 9 16
FENTANYL 145 30 S2 10 10
OXYCODONE-ACETAMINOPHEN 143 54 S2 11 5
OXYCODONE HCL-ACETAMINOPHEN 136 48 S2 12 7
OPANA ER 129 11 S2 13 19
HYDROCODONE-ACETAMINOPHEN 128 72 S3 14 4
ZOLPIDEM TARTRATE 121 16 15 21
TIZANIDINE HCL 102 15 16 22
TOPIRAMATE 93 16 17 23
OXYMORPHONE HCL 92 36 S2 18 24
MORPHINE SULFATE 81 0 S2 19 25
POLYETHYLENE GLYCOL 3350 77 0 20 26
LYRICA 76 22 21 15
IBUPROFEN 75 0 22 19
NAPROXEN 73 0 23 18
METHADONE HCL 72 11 S2 24 14
AMITRIPTYLINE HCL 71 0 R 25 27
CYMBALTA 68 13 26 28
TRAZODONE HCL 56 12 27 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.